RVP Company Profile and Key Details

Short-term trend indicators are bullishly aligned (SMA20 -1.14%, SMA50 -8.54%, SMA200 -13.16%). The stock’s 14-day RSI is 43.31 (neutral), while the ATR of 0.04 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -41.4% below its high and over 7.74% above its low. Average 10-day trading volume of 111.50 thousand shares is slightly above the 3-month average of 79.40 thousand, indicating heightened recent market interest.

Retractable Technologies, Inc. has 29.94 million shares outstanding. The public float is 12.44 million shares, elevated short interest at 0.27% of float. This equals 34.41 thousand shares. The short ratio is 0.66 days. Institutional investors hold 21.57% of the float. Insiders own 59.23%. SHAW THOMAS J holds 15.83 million shares, Leonard Braden Michael has 688.58 thousand shares and Bigby Walter O Jr has 80.00 thousand shares.

Retractable Technologies, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around -$0.46. This means the shares are trading below this model’s fair value.

Retractable Technologies, Inc. (AMEX:RVP) closed at $0.68 USD, losing -$0.02 (-3.19%) from the previous close of $0.70. The stock is currently mid-range between its 52-week high and low $0.60 and $1.14. With a market capitalization of about $20.28 million, Retractable Technologies, Inc. is classified as a micro-cap and shows market-like volatility (beta ~1.25). Key stats such as the average daily volume over the past year has been around 96.03 thousand shares, volume is running light vs its 52-week average. Headquartered in Little Elm, TX, Retractable Technologies, Inc. operates in the Healthcare sector and the Medical - Instruments & Supplies industry. Led by CEO Thomas J. Shaw, the company employs approximately 221 people and listed since May 04, 2001. Retractable Technologies, Inc. is a medical device company focused on the innovation, production, and sale of secure medical instruments, predominantly syringes, for the healthcare sector.

Retractable Technologies, Inc. trades at a P/E ratio of -3.19, slightly below the S&P 500 average, with a price-to-sales ratio of 0.54 and a price-to-book ratio of 0.29 suggesting the stock is closer to book value. The P/FCF stands at -2.71, also above market averages.

Retractable Technologies, Inc. (AMEX:RVP) shares are flat -6.53% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows Retractable Technologies, Inc. trading at a premium to the broader market with a P/E of -3.19. Our AI forecast model points to short-term strength (0.04% over two weeks), a medium-term rise (34.34% over three months), and a longer-term gain (1416.36% over one year), with expected trading ranges indicating moderate volatility.

Our AI price prediction model suggests that Retractable Technologies, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 0.04%, with price expected at $0.70 by June 26, 2026, within a range of $0.67 to $0.73 3-Month Outlook: Projected rise of 34.34%, reaching $0.94 by September 10, 2026, with a range of $0.90 to $0.97. 1-Year Outlook: Projected gain of 1416.36%, with price at $10.61 by June 11, 2027, within a range of $3.61 to $15.81.